BEIJING, Oct. 9, 2023 /PRNewswire/ — From learning Chinese by herself to becoming the apprentice of…
Day: October 9, 2023
TAILG Breaks Guinness World Record by Achieving “Longest Journey on An Electric Scooter”
DONGGUAN, China, Oct. 9, 2023 /PRNewswire/ — TAILG, a world-leading e-mobility solution provider and a green mobility…
VinCSS Applauded by Frost & Sullivan for Reducing Security Risks Associated with Traditional Authentication Technologies with Its Passwordless Authentication Ecosystem
VinCSS’s passwordless authentication ecosystem eliminates reliance on passwords, simplifying identity and access management (IAM) strategies and enhancing operational efficiency.…
bolttech Insurance and Trip.com forge partnership to launch in-app insurance service in Hong Kong
HONG KONG, Oct. 9, 2023 /PRNewswire/ — bolttech Insurance, the Hong Kong general insurance arm of international…
Lazada Group and Seoul Business Agency Forge Strategic Partnership to Create eCommerce Opportunities for South Korean SMEs in Southeast Asia
Partnership to expand opportunities for Seoul-based small and medium enterprises (SMEs) by tapping into Lazada’s platform…
Valtech Valuation provides LSP valuation under new legislation
HONG KONG, Oct. 9, 2023 /PRNewswire/ — Valtech Valuation has updated and enhanced their LSP valuation…
PEZA Confident of more Chinese Investments Pouring in the Philippines after 20th CAEXPO
Short link: https://wp.me/paaccn-xKY PASAY CITY – Philippine Economic Zone Authority (PEZA) Director General Tereso O. Panga…
CrossFund Raises Additional $1.5M in Funding at a $47M Valuation, Establishes Itself as Leading Investment Gateway to the Emerging World
SINGAPORE, Oct. 9, 2023 /PRNewswire/ — Fintech startup, CrossFund, has raised its fourth funding round in…
Emerging Leader IX Technology Makes Strides in Expanding Footprint to Vietnam and Malaysia
SINGAPORE, Oct. 9, 2023 /PRNewswire/ — IX Technology (IXT), a leading Singapore-based provider of data centre mechanical…
Innovent Announces First Patient Dosed in the Phase 3 Clinical Study (STAR) of Efdamrofusp Alfa (IBI302), a First-in-class Ophthalmic Anti-VEGF and Anti-Complement Bispecific Fusion Protein for the Treatment of Neovascular Age-related Macular Degeneration
ROCKVILLE, Md. and SUZHOU, China, Oct. 9, 2023 /PRNewswire/ — Innovent Biologics, Inc. ("Innovent") (HKEX: 01801),…